The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion
Publication
, Conference
Hjelmeland, AB; Lattimore, K; Fee, B; Wickman, S; Keir, ST; Hjelmeland, MD; Batt, D; Lane, H; Bigner, DD; Friedman, HS; Rich, JN
Published in: NEURO-ONCOLOGY
October 1, 2006
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2006
Volume
8
Issue
4
Start / End Page
412 / 412
Location
Vienna, AUSTRIA
Publisher
DUKE UNIV PRESS
Conference Name
7th Congress of the European-Association-for-Neuro-Oncology (EANO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hjelmeland, A. B., Lattimore, K., Fee, B., Wickman, S., Keir, S. T., Hjelmeland, M. D., … Rich, J. N. (2006). The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion. In NEURO-ONCOLOGY (Vol. 8, pp. 412–412). Vienna, AUSTRIA: DUKE UNIV PRESS.
Hjelmeland, Anita B., Katie Lattimore, Brian Fee, Sarah Wickman, Stephen T. Keir, Mark D. Hjelmeland, David Batt, et al. “The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion.” In NEURO-ONCOLOGY, 8:412–412. DUKE UNIV PRESS, 2006.
Hjelmeland AB, Lattimore K, Fee B, Wickman S, Keir ST, Hjelmeland MD, et al. The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 412–412.
Hjelmeland, Anita B., et al. “The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion.” NEURO-ONCOLOGY, vol. 8, no. 4, DUKE UNIV PRESS, 2006, pp. 412–412.
Hjelmeland AB, Lattimore K, Fee B, Wickman S, Keir ST, Hjelmeland MD, Batt D, Lane H, Bigner DD, Friedman HS, Rich JN. The combination of novel low-molecular-weight inhibitors of Raf (LBT 613) and TOR (RAD001, everolimus) decreases glioma proliferation and invasion. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 412–412.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2006
Volume
8
Issue
4
Start / End Page
412 / 412
Location
Vienna, AUSTRIA
Publisher
DUKE UNIV PRESS
Conference Name
7th Congress of the European-Association-for-Neuro-Oncology (EANO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences